Oncozenge AB (ST:ONCOZ) — Stock Price

Skr3.21 SEK
▼ -0.31% today

Oncozenge AB (ST:ONCOZ) is currently trading at Skr3.21 SEK, down 0.31% today. Over the past 52 weeks, shares have ranged between Skr3.20 and Skr8.36. This page tracks Oncozenge AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see ONCOZ cash flow conversion.

Oncozenge AB (ONCOZ) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Oncozenge AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Oncozenge AB Income Statement — Revenue, Profit & Earnings by Year

Oncozenge AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr2.66 Million Skr1.00K Skr3.00K Skr0.00 Skr0.00
Cost of Revenue Skr7.50 Million — — Skr0.00 Skr0.00
Gross Profit Skr-4.84 Million Skr1.00K Skr3.00K Skr0.00 Skr0.00
Research & Development Skr11.03 Million Skr1.72 Million Skr7.39 Million Skr37.64 Million Skr216.00K
SG&A — — Skr7.19 Million Skr5.93 Million Skr4.68 Million
Total Operating Expenses Skr11.03 Million Skr8.69 Million Skr15.90 Million Skr43.57 Million Skr4.89 Million
Operating Income Skr-15.87 Million Skr-8.69 Million Skr-15.90 Million Skr-43.57 Million Skr-4.89 Million
EBITDA Skr-15.87 Million Skr-8.69 Million Skr7.27 Million Skr2.77 Million Skr-4.89 Million
EBIT — — Skr-15.90 Million Skr-20.40 Million Skr-4.89 Million
Interest Expense Skr169.00K Skr4.00K Skr0.00 Skr0.00 Skr0.00
Income Before Tax Skr-15.94 Million Skr-8.69 Million Skr-15.90 Million Skr-43.57 Million Skr-4.89 Million
Income Tax Expense — — Skr-23.17 Million Skr3.08 Million Skr-1.01 Million
Net Income Skr-15.94 Million Skr-8.69 Million Skr-15.90 Million Skr-46.65 Million Skr-3.89 Million

Oncozenge AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Oncozenge AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr15.34 Million Skr11.43 Million Skr20.34 Million Skr36.89 Million Skr85.23 Million
Total Current Assets Skr8.49 Million Skr4.58 Million Skr13.49 Million Skr30.04 Million Skr52.13 Million
Cash & Equivalents — — — — —
Short-term Investments — — — — —
Net Receivables Skr4.77 Million Skr721.00K Skr829.00K Skr903.00K Skr914.00K
Inventory — — Skr-863.00K Skr-903.00 Skr-914.00
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Total Liabilities Skr15.92 Million Skr1.48 Million Skr1.70 Million Skr2.92 Million Skr4.90 Million
Total Current Liabilities Skr8.42 Million Skr1.48 Million Skr1.70 Million Skr2.92 Million Skr4.90 Million
Long-term Debt Skr7.50 Million Skr0.00 — — —
Net Debt Skr3.79 Million Skr-3.86 Million Skr-12.63 Million Skr-29.14 Million Skr-51.22 Million
Total Stockholder Equity Skr-587.00K Skr9.95 Million Skr18.64 Million Skr33.97 Million Skr80.32 Million
Retained Earnings Skr-91.70 Million Skr-75.76 Million Skr-67.07 Million Skr-51.17 Million Skr-27.69 Million

Oncozenge AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Oncozenge AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-13.06 Million Skr-8.76 Million Skr-17.08 Million Skr-22.08 Million Skr-4.77 Million
Capital Expenditures Skr13.06 Million Skr0.00 Skr0.00 Skr0.00 Skr5.36 Million
Free Cash Flow Skr-13.06 Million Skr-8.76 Million Skr-17.08 Million Skr-22.08 Million Skr-10.12 Million
Investing Cash Flow — — Skr570.00K — Skr-5.36 Million
Financing Cash Flow Skr12.91 Million — Skr570.00K — Skr51.34 Million
Dividends Paid — — — — —
Stock-Based Compensation — Skr0.00 Skr0.00 Skr296.00K Skr0.00
Depreciation — — — Skr23.17 Million Skr23.17 Million
Change in Cash Skr-149.00K Skr-8.76 Million Skr-16.51 Million Skr-22.08 Million Skr41.22 Million

Oncozenge AB Earnings History — EPS Actual vs. Analyst Estimates

Track Oncozenge AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Dec 31, 2025 -0.78 — —
Sep 30, 2025 -0.28 — —
Jun 30, 2025 -0.22 — —
May 15, 2025 0.00 — —
Feb 20, 2025 -0.21 — —
Nov 18, 2024 -0.15 — —
Aug 09, 2024 -0.18 — —
May 21, 2024 -0.20 — —